Filing Details

Accession Number:
0001209191-14-047793
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-07-17 16:18:12
Reporting Period:
2014-07-15
Filing Date:
2014-07-17
Accepted Time:
2014-07-17 16:18:12
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
57725 Lannett Co Inc LCI Pharmaceutical Preparations (2834) 230787699
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1262311 David Farber 13200 Townsend Road
Philadelphia PA 19154
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2014-07-15 5,000 $47.20 80,870 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 4,581,581 Indirect Various
Footnotes
  1. This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Farber on March 27, 2014. The 10b5-1 trading plan will allow Mr. Farber to diversify a portion of his holdings consistent with SEC Rule 10b5-1 and the Company's Insider Trading Policy.
  2. Includes 3,850,000 shares held by FPG. FPG is managed and jointly owned by Jeffrey Farber and David Farber. David Farber and Jeffrey Farber each disclaim beneficial ownership of 1,925,000 shares held by FPG. Includes 528,142 shares held by FFLLC which is managed by Jeffrey and David Farber. David Farber and Jeffrey Farber each disclaim beneficial ownership of these shares. Includes 148,160 shares held by David Farber as custodian for his children and 17,279 shares held as joint custodian with Jeffrey Farber for a relative. Also includes 38,000 shares held by FIC. Jeffrey Farber and David Farber each beneficially own 25% of FIC and each disclaim beneficial ownership of all but 9,500 shares held by FIC.